China Universal Asset Management Company’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$534K Sell
12,500
-12,500
-50% -$679K 0.03% 259
2026
Q1
$1.57M Buy
25,000
+15,000
+150% +$1.2M 0.12% 134
2025
Q4
$954K Sell
10,000
-22,000
-69% -$2.16M 0.07% 193
2025
Q3
$3.12M Buy
32,000
+5,424
+20% +$562K 0.26% 78
2025
Q2
$2.85M Buy
26,576
+8,139
+44% +$824K 0.27% 78
2025
Q1
$1.86M Buy
18,437
+5,294
+40% +$533K 0.17% 116
2024
Q4
$1.17M Buy
+13,143
New +$1.16M 0.11% 141
2024
Q2
Sell
-240
Closed -$16.4K 416
2024
Q1
$16.4K Buy
+240
New +$15.4K ﹤0.01% 430

Other funds holding BSX

China Universal Asset Management Company's BSX Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Boston Scientific (BSX) stake by 50% in Q2 2026, selling an estimated $679K and leaving 12,500 shares worth $534K. The position accounts for 0.03% of the portfolio, ranked #259.

China Universal Asset Management Company first reported a position in BSX in Q1 2024 and has held it in 8 quarters since. The position peaked at $3.12M in Q3 2025. 1,001 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • China Universal Asset Management Company held 12,500 shares of Boston Scientific worth $534K as of Q2 2026.
  • China Universal Asset Management Company sold 12,500 Boston Scientific shares in Q2 2026, an estimated $679K.
  • Boston Scientific made up 0.03% of China Universal Asset Management Company's portfolio in Q2 2026, its #259 holding.
  • China Universal Asset Management Company first reported a position in Boston Scientific in Q1 2024 and has held it in 8 quarters since.
  • China Universal Asset Management Company's Boston Scientific position peaked at $3.12M in Q3 2025.
  • 1,001 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.